CVM
Price
$9.14
Change
-$0.31 (-3.28%)
Updated
Aug 4, 04:59 PM (EDT)
Capitalization
47.5M
SVRA
Price
$2.58
Change
-$0.01 (-0.39%)
Updated
Aug 4, 04:59 PM (EDT)
Capitalization
444.19M
2 days until earnings call
Interact to see
Advertisement

CVM vs SVRA

Header iconCVM vs SVRA Comparison
Open Charts CVM vs SVRABanner chart's image
Cel-Sci
Price$9.14
Change-$0.31 (-3.28%)
Volume$3.59K
Capitalization47.5M
Savara
Price$2.58
Change-$0.01 (-0.39%)
Volume$39.99K
Capitalization444.19M
CVM vs SVRA Comparison Chart in %
Loading...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Sarepta Therapeutics (NASDAQ:SRPT), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.32B. The market cap for tickers in the group ranges from 58 to 213.02B. NONOF holds the highest valuation in this group at 213.02B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -3%. For the same Industry, the average monthly price growth was 15%, and the average quarterly price growth was 11%. JWCTF experienced the highest price growth at 158%, while VYNE experienced the biggest fall at -75%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -2%. For the same stocks of the Industry, the average monthly volume growth was 21% and the average quarterly volume growth was 104%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 83
Price Growth Rating: 59
SMR Rating: 92
Profit Risk Rating: 95
Seasonality Score: -11 (-100 ... +100)

Notable companies

The most notable companies in this group are Cel-Sci Corp (ASE:CVM).

Market Cap

The average market capitalization across the group is 245.84M. The market cap for tickers in the group ranges from 47.5M to 444.19M. SVRA holds the highest valuation in this group at 444.19M. The lowest valued company is CVM at 47.5M.

High and low price notable news

The average weekly price growth across all stocks in the group was 2%. For the same group, the average monthly price growth was 144%, and the average quarterly price growth was -16%. CVM experienced the highest price growth at 7%, while SVRA experienced the biggest fall at -3%.

Volume

The average weekly volume growth across all stocks in the group was -24%. For the same stocks of the group, the average monthly volume growth was 50% and the average quarterly volume growth was 2,547%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 83
P/E Growth Rating: 74
Price Growth Rating: 46
SMR Rating: 98
Profit Risk Rating: 94
Seasonality Score: -22 (-100 ... +100)
VS
CVM vs. SVRA commentary
Aug 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVM is a Hold and SVRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 05, 2025
Stock price -- (CVM: $9.25 vs. SVRA: $2.57)
Brand notoriety: CVM: Notable vs. SVRA: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVM: 34% vs. SVRA: 107%
Market capitalization -- CVM: $47.5M vs. SVRA: $444.19M
CVM [@Biotechnology] is valued at $47.5M. SVRA’s [@Biotechnology] market capitalization is $444.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVM’s FA Score shows that 0 FA rating(s) are green whileSVRA’s FA Score has 0 green FA rating(s).

  • CVM’s FA Score: 0 green, 5 red.
  • SVRA’s FA Score: 0 green, 5 red.
According to our system of comparison, CVM is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVM’s TA Score shows that 5 TA indicator(s) are bullish while SVRA’s TA Score has 5 bullish TA indicator(s).

  • CVM’s TA Score: 5 bullish, 4 bearish.
  • SVRA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SVRA is a better buy in the short-term than CVM.

Price Growth

CVM (@Biotechnology) experienced а +7.43% price change this week, while SVRA (@Biotechnology) price change was -3.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.94%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +10.52%.

Reported Earning Dates

CVM is expected to report earnings on May 15, 2025.

SVRA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-2.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SVRA($444M) has a higher market cap than CVM($47.5M). SVRA YTD gains are higher at: -16.287 vs. CVM (-22.897). CVM has higher annual earnings (EBITDA): -21.96M vs. SVRA (-108.24M). SVRA has more cash in the bank: 172M vs. CVM (1.92M). CVM has less debt than SVRA: CVM (10.5M) vs SVRA (29.6M). CVM (0) and SVRA (0) have equivalent revenues.
CVMSVRACVM / SVRA
Capitalization47.5M444M11%
EBITDA-21.96M-108.24M20%
Gain YTD-22.897-16.287141%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.92M172M1%
Total Debt10.5M29.6M35%
FUNDAMENTALS RATINGS
CVM vs SVRA: Fundamental Ratings
CVM
SVRA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
10088
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
3459
P/E GROWTH RATING
1..100
49100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SVRA's Valuation (68) in the Biotechnology industry is in the same range as CVM (98). This means that SVRA’s stock grew similarly to CVM’s over the last 12 months.

SVRA's Profit vs Risk Rating (88) in the Biotechnology industry is in the same range as CVM (100). This means that SVRA’s stock grew similarly to CVM’s over the last 12 months.

SVRA's SMR Rating (97) in the Biotechnology industry is in the same range as CVM (100). This means that SVRA’s stock grew similarly to CVM’s over the last 12 months.

CVM's Price Growth Rating (34) in the Biotechnology industry is in the same range as SVRA (59). This means that CVM’s stock grew similarly to SVRA’s over the last 12 months.

CVM's P/E Growth Rating (49) in the Biotechnology industry is somewhat better than the same rating for SVRA (100). This means that CVM’s stock grew somewhat faster than SVRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CVMSVRA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 29 days ago
90%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMICX22.40N/A
N/A
GMO International Equity II
FMIEX10.30N/A
N/A
Wasatch Global Value Investor
GABEX5.87N/A
N/A
Gabelli Equity Income AAA
CVMIX19.90N/A
N/A
Calvert Emerging Markets Equity I
FUMIX18.68N/A
N/A
Fidelity SAI US Momentum Index

CVM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CVM has been loosely correlated with NRXS. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CVM jumps, then NRXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVM
1D Price
Change %
CVM100%
-2.12%
NRXS - CVM
58%
Loosely correlated
+0.80%
MDGL - CVM
43%
Loosely correlated
+3.14%
CYTK - CVM
40%
Loosely correlated
-0.30%
ADXN - CVM
39%
Loosely correlated
+0.37%
EYPT - CVM
38%
Loosely correlated
+3.60%
More

SVRA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with RCKT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
-0.77%
RCKT - SVRA
62%
Loosely correlated
+2.68%
PRTA - SVRA
46%
Loosely correlated
+1.91%
RVMD - SVRA
41%
Loosely correlated
+1.50%
CCCC - SVRA
40%
Loosely correlated
-0.94%
CRNX - SVRA
39%
Loosely correlated
+1.36%
More